Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060765

EVP and Chief Medical Officer sold 359 shares at $81.14 ($29,129)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · EVP and Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-10-14 Sale : show line 1 in the form −359 $81.14 $29,129 38,416 D
Open-market sales · 359 sh · avg $81.14 · $29,129
Loading xslF345X03/doc4.xml…